WGU D027 Final Exam Comprehensive Study Guide (Latest 2023/ 2024 Update) Advanced Pathopharmacological Foundations| Questions and Verified Answers| 100% Correct| Grade A

WGU D027 Final Exam Comprehensive Study Guide (Latest 2023/ 2024 Update) Advanced Pathopharmacological Foundations| Questions and Verified Answers| 100% Correct| Grade A Q: primary malignant tumor Answer: lack of organization of cells Q: glucocorticoids Answer: used in combination with other agent to treat lymphoid tissue (leukemia). glucocorticoids are directly toxic to lymphoid tissues. Q: Selective estrogen receptor modulators (SERM) Answer: for hormone receptor positive and advanced breast cancer. (Tamoxifin reduces risk and recurrence risk) Q: Heart failure Answer: impairment of the ventricle to fill with or eject blood; heart cannot meet metabolic need of the body. Q: CHF Answer: heart cannot keep up with metabolic needs; volume overload in pulmonary area Q: Left Ventricular Dysfunction Answer: reduced ejection fraction; ventricle having issue ejecting blood. Q: normal ejection fraction Answer: 55 - 60 % (blood pumped out with each heartbeat) Q: Ejection fraction of 50% - reduced or preserved? Answer: preserved Q: Diastolic CHF Answer: preserved ejection fraction, problem is with filling Q: Systolic CHF Answer: reduced ejection fraction, problem is with ejecting Q: Left sided CHF Answer: pulmonary (JVD, fluid volume overload, rails, S-3 murmurs) ** #1 cause of Right sided CHF Q: BNP Answer: gold standard lab test to diagnose CHF Q: Echocardiogram Answer: Diagnostic tool, evaluates heart structure and function Q: At Risk for HF - Stage A Answer: no structural heart disease or symptoms of heart failure Q: Stage A HF co-morbidities htn, atherosclerotic disease, diabetes, metabolic syndrome, patients using cardiotoxins with family history